Titles and Roles
- Professor, Department of Hematology and Medical Oncology
- Winship Cancer Institute of Emory University
- Research Program
- Discovery and Developmental Therapeutics
In 2002, Dr. Chen joined the University of Pittsburgh Cancer Institute as an Associate Professor. Two years later, she joined Emory University, Winship Cancer Institute with the same title. Dr. Chen is a Georgia Cancer Coalition Distinguished Cancer Scholar. Including her studies at the University of Texas Dental Branch, M.D. Anderson Cancer Center, and the University of Pittsburgh Cancer Institute, Dr. Chen has conducted research in the areas of lung and head and neck cancers for nineteen years.
In 1982, Dr. Georgia Zhuo received her BS from the Beijing Institute of Chemical Technology. She then went on to receive her PhD from Louisiana State University, USA, in 1989. After postdoctoral training, she received her first faculty position at the University of Texas Dental Branch, as a Research Assistant Professor in 1992. She then was elevated to the tenure track position at M.D. Anderson Cancer Center in 1998.
As principal investigator in the study of head and neck cancer, her work has been supported over the past few years by several awards from the US National Institutes of Health (NIH). In 2014, she was named to the MilliPub Club, which recognizes current Emory faculty who have published one or more individual papers throughout their careers that have each garnered more than 1,000 citations.
Dr. Chen's research focuses on the metastasis of head and neck cancer, signal transduction pathways in cancer cells, prognostic and therapeutic biomarkers, anticancer therapeutic drugs for treatment of cancer,and usage of nanotechnology in cancer research and clinical application.She has established a human xenograft metastatic mouse model for head and neck cancer, which has been used in studying the biology of cancer and in the evaluation of therapeutic agents for cancer treatment. Dr. Chen is a well-trained molecular oncologist with experience in the molecular analyses of oncogene expression, gene regulation, cellular signal transduction, and using animal models for lung and head and neck cancer.
Currently, she is a Project Leader for the Head and Neck Cancer SPORE supported by NIH, and a project funded by the US Department of Defense. She also served as PI on a project for identifying metastasis–related proteins in head and neck cancer using nanotechnology, and as a co-investigator for several projects related to prevention and treatment of lung and head and neck cancers using targeted small molecules and nanotherapeutic drugs. These studies have generated 72 publications in peer-reviewed journals.